Editor's Note The lack of available hearts for transplantation combined with the recent recall of Abbott’s HeartMate 3 left ventricular assist device (LVAD) “makes the current therapy landscape for heart failure much more dire,” according to a May 20 report in Medical Device Network. The recall of the device, which…
Editor's Note More than 45 years after surgery, Mary Ann Kozlowski’s mechanical heart valves are still pumping—and Guinness is reviewing an application to list her as the new world record-holder for longevity of a double-valve replacement. That’s according to a May 15 report in the Erie-Times News, which detailed how…
Editor's Note Nine out of 10 American adults have Cardiovascular, kidney, and metabolic syndrome (CKM)—interrelated factors that progress to heart disease—and almost 10% already have heart disease, according to a report published in JAMA by Brigham and Women’s Hospital and Harvard Medical School in Boston. HealthDay news reported on the…
Editor's Note The US Food and Drug Administration (FDA) has classified recalls of Abbot’s HeartMate 3 Left Ventricular Assist System (LVAS) implant kits and Phillips Respironics' Trilogy Evo ventilators as class 1, the most serious category indicating risk of serious injury or death. Used while waiting for recovery, a transplant,…
The US Food & Drug Administration (FDA) announced a Class 1 recall on Monday for Abbott/Thoratec Corp.’s HeartMate II and HeartMate 3 Left Ventricular Assist System (LVAS) due due to biological material buildup obstructing the devices. According to an April 16 CBS News report, surgeons first noticed problems with the…
Editor's Note New research shows transplant center teams are more to likely reject offers of donor hearts to black men and men than black women and white women, MedPage Today reported on March 25. “The cumulative probability of a donor heart being accepted by the transplant center team was most…
Editor's Note Although cardiac disease is the leading cause of human morbidity and mortality globally, the complexity of cardiac tissues makes monitoring difficult. To address this issue, a team from University of Massachusetts Amherst and MIT has created a bioelectronic mesh system that can measure movement of cells in cardiac…
Editor's Note The American College of Cardiology (ACC) has introduced the CV ASC Registry Suite, a pioneering data registry targeting cardiac procedures at ambulatory surgical centers (ASCs), Cardiovascular Business February 13 reports. This initiative marks a significant development that reflects the trend of cardiac care shifting from hospitals to ASCs.…
Editor's Note Using intravascular imaging to guide stent implantation during percutaneous coronary intervention (PCI) provides significantly better outcomes than angiography, according to findings published February 21 in The Lancet. In a study of 15,964 patients undergoing PCI from 22 trials in hundreds of centers from March 2010 to August 2023,…
Editor's Note Patients with severe cases of tricuspid regurgitation (in which a critical heart valve fails to close properly) now have a new treatment option thanks to the recent US Food and Drug Administration (FDA) approval of the ENVOQUE tricuspid valve replacement system, according to a February 2 press release…